Literature DB >> 11861394

Silence of chromosomal amplifications in colon cancer.

Petra Platzer1, Madhvi B Upender, Keith Wilson, Joseph Willis, James Lutterbaugh, Arman Nosrati, James K V Willson, David Mack, Thomas Ried, Sanford Markowitz.   

Abstract

Oncogene activation by gene amplification is a major pathogenetic mechanism in human cancer. Using comparative genomic hybridization, we determined that metastatic human colon cancers commonly acquire numerous extra copies of chromosome arms 7p, 8q, 13q, and 20q. We then examined the consequence of these amplifications on gene expression using DNA microarrays. Of 55,000 transcripts profiled, 2,146 were determined to map to one of the four common colon cancer amplicons and to also be expressed in normal or malignant colon tissues. Of these, only 81 transcripts (3.8%) demonstrated a 2-fold increase over normal expression among cancers bearing the corresponding chromosomal amplification. Chromosomal amplifications are common in colon cancer metastasis, but increased expression of genes within these amplicons is rare.

Entities:  

Mesh:

Year:  2002        PMID: 11861394

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  53 in total

1.  Digital karyotyping.

Authors:  Tian-Li Wang; Christine Maierhofer; Michael R Speicher; Christoph Lengauer; Bert Vogelstein; Kenneth W Kinzler; Victor E Velculescu
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-02       Impact factor: 11.205

2.  Topography of genetic loci in the nuclei of cells of colorectal carcinoma and adjacent tissue of colonic epithelium.

Authors:  Emilie Lukásová; Stanislav Kozubek; Martin Falk; Michal Kozubek; Jan Zaloudík; Václav Vagunda; Zdenek Pavlovský
Journal:  Chromosoma       Date:  2004-01-13       Impact factor: 4.316

3.  Expressive genomic hybridisation: gene expression profiling at the cytogenetic level.

Authors:  F Al-Mulla; M Al-Maghrebi; G Varadharaj
Journal:  Mol Pathol       Date:  2003-08

4.  Colorectal adenomas and cancer link to chromosome 13q22.1-13q31.3 in a large family with excess colorectal cancer.

Authors:  Deborah W Neklason; Thérèse M Tuohy; Jeffery Stevens; Brith Otterud; Lisa Baird; Richard A Kerber; Wade S Samowitz; Scott K Kuwada; Mark F Leppert; Randall W Burt
Journal:  J Med Genet       Date:  2010-06-03       Impact factor: 6.318

5.  Mutated KRAS results in overexpression of DUSP4, a MAP-kinase phosphatase, and SMYD3, a histone methyltransferase, in rectal carcinomas.

Authors:  Jochen Gaedcke; Marian Grade; Klaus Jung; Jordi Camps; Peter Jo; Georg Emons; Anastasia Gehoff; Ulrich Sax; Markus Schirmer; Heinz Becker; Tim Beissbarth; Thomas Ried; B Michael Ghadimi
Journal:  Genes Chromosomes Cancer       Date:  2010-11       Impact factor: 5.006

Review 6.  Patterns of Chromosomal Aberrations in Solid Tumors.

Authors:  Marian Grade; Michael J Difilippantonio; Jordi Camps
Journal:  Recent Results Cancer Res       Date:  2015

7.  A comprehensive continuous-time model for the appearance of CGH signal due to chromosomal missegregations during mitosis.

Authors:  Richard Desper; Michael J Difilippantonio; Thomas Ried; Alejandro A Schäffer
Journal:  Math Biosci       Date:  2005-09       Impact factor: 2.144

8.  15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers.

Authors:  Min Yan; Ronald M Rerko; Petra Platzer; Dawn Dawson; Joseph Willis; Min Tong; Earl Lawrence; James Lutterbaugh; Shilong Lu; James K V Willson; Guangbin Luo; Jack Hensold; Hsin-Hsiung Tai; Keith Wilson; Sanford D Markowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-01       Impact factor: 11.205

9.  Vascular Endothelial Growth Factor Receptor-1 Is Synthetic Lethal to Aberrant {beta}-Catenin Activation in Colon Cancer.

Authors:  Snehal Naik; Robin S Dothager; Jayne Marasa; Cory L Lewis; David Piwnica-Worms
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

10.  The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers.

Authors:  Chunguang Guo; Jerome F Sah; Lydia Beard; James K V Willson; Sanford D Markowitz; Kishore Guda
Journal:  Genes Chromosomes Cancer       Date:  2008-11       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.